Protocol of a scoping review of outcome domains in dermatology
Introduction Core outcome sets (COSs) are agreed outcomes (domains (subdomains) and instruments) that should be measured as a minimum in clinical trials or practice in certain diseases or clinical fields. Worldwide, the number of COSs is increasing and there might be conceptual overlaps of domains (...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/2/e079632.full |
_version_ | 1797271164827992064 |
---|---|
author | Jamie J Kirkham Amit Garg Gregor Borut Ernst Jemec Murad Alam Phyllis I Spuls John R Ingram Jan Kottner K Ezzedine Umer Nadir Areeba Ahmed Michael D Yi Farhana Ikmal Hisham Loma Dave Brian Cahn |
author_facet | Jamie J Kirkham Amit Garg Gregor Borut Ernst Jemec Murad Alam Phyllis I Spuls John R Ingram Jan Kottner K Ezzedine Umer Nadir Areeba Ahmed Michael D Yi Farhana Ikmal Hisham Loma Dave Brian Cahn |
author_sort | Jamie J Kirkham |
collection | DOAJ |
description | Introduction Core outcome sets (COSs) are agreed outcomes (domains (subdomains) and instruments) that should be measured as a minimum in clinical trials or practice in certain diseases or clinical fields. Worldwide, the number of COSs is increasing and there might be conceptual overlaps of domains (subdomains) and instruments within disciplines. The aim of this scoping review is to map and to classify all outcomes identified with COS projects relating to skin diseases.Methods and analysis We will conduct a scoping review of outcomes of skin disease-related COS initiatives to identify all concepts and their definitions. We will search PubMed, Embase and Cochrane library. The search dates will be 1 January 2010 (the point at which Core Outcome Measures in Effectiveness Trials (COMET) was established) to 1 January 2024. We will also review the COMET database and C3 website to identify parts of COSs (domains and/or instruments) that are being developed and published. This review will be supplemented by querying relevant stakeholders from COS organisations, dermatology organisations and patient organisations for additional COSs that were developed. The resulting long lists of outcomes will then be mapped into conceptually similar concepts.Ethics and dissemination This study was supported by departmental research funds from the Department of Dermatology at Northwestern University. An ethics committee review was waived since this protocol was done by staff researchers with no involvement of patient care. Conflicts of interests, if any, will be addressed by replacing participants with relevant conflicts or reassigning them. The results will be disseminated through publication in peer-reviewed journals, social media posts and promotion by COS organisations. |
first_indexed | 2024-03-07T13:57:53Z |
format | Article |
id | doaj.art-254130c33e8e42c785d893763ff37ef8 |
institution | Directory Open Access Journal |
issn | 2044-6055 |
language | English |
last_indexed | 2024-03-07T13:57:53Z |
publishDate | 2024-02-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Open |
spelling | doaj.art-254130c33e8e42c785d893763ff37ef82024-03-07T07:10:09ZengBMJ Publishing GroupBMJ Open2044-60552024-02-0114210.1136/bmjopen-2023-079632Protocol of a scoping review of outcome domains in dermatologyJamie J Kirkham0Amit Garg1Gregor Borut Ernst Jemec2Murad Alam3Phyllis I Spuls4John R Ingram5Jan Kottner6K Ezzedine7Umer Nadir8Areeba Ahmed9Michael D Yi10Farhana Ikmal Hisham11Loma Dave12Brian Cahn13Biostatistics, Manchester University, Manchester, UKDepartment of Dermatology, Hofstra Northwell School of Medicine, Long Island, New York, USADermatology, Roskilde University Hospital, Roskilde, DenmarkDermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USADepartment of Dermatology, Amsterdam UMC, location Academic Medical Center, University of Amsterdam, Amsterdam Public Health, Infection and Immunity, Amsterdam, NetherlandsCardiff University, Cardiff, UKCharité Universitätsmedizin Berlin, Berlin, GermanyService de Dermatologie, AP-HP, Henri Mondor Hospital, Paris, FranceDepartment of Dermatology, Feinberg School of Medicine, Chicago, Illinois, USADepartment of Dermatology, Feinberg School of Medicine, Chicago, Illinois, USADepartment of Dermatology, Feinberg School of Medicine, Chicago, Illinois, USADepartment of Dermatology, Feinberg School of Medicine, Chicago, Illinois, USADepartment of Dermatology, Feinberg School of Medicine, Chicago, Illinois, USADepartment of Dermatology, University of Illinois, Chicago, Illinois, USAIntroduction Core outcome sets (COSs) are agreed outcomes (domains (subdomains) and instruments) that should be measured as a minimum in clinical trials or practice in certain diseases or clinical fields. Worldwide, the number of COSs is increasing and there might be conceptual overlaps of domains (subdomains) and instruments within disciplines. The aim of this scoping review is to map and to classify all outcomes identified with COS projects relating to skin diseases.Methods and analysis We will conduct a scoping review of outcomes of skin disease-related COS initiatives to identify all concepts and their definitions. We will search PubMed, Embase and Cochrane library. The search dates will be 1 January 2010 (the point at which Core Outcome Measures in Effectiveness Trials (COMET) was established) to 1 January 2024. We will also review the COMET database and C3 website to identify parts of COSs (domains and/or instruments) that are being developed and published. This review will be supplemented by querying relevant stakeholders from COS organisations, dermatology organisations and patient organisations for additional COSs that were developed. The resulting long lists of outcomes will then be mapped into conceptually similar concepts.Ethics and dissemination This study was supported by departmental research funds from the Department of Dermatology at Northwestern University. An ethics committee review was waived since this protocol was done by staff researchers with no involvement of patient care. Conflicts of interests, if any, will be addressed by replacing participants with relevant conflicts or reassigning them. The results will be disseminated through publication in peer-reviewed journals, social media posts and promotion by COS organisations.https://bmjopen.bmj.com/content/14/2/e079632.full |
spellingShingle | Jamie J Kirkham Amit Garg Gregor Borut Ernst Jemec Murad Alam Phyllis I Spuls John R Ingram Jan Kottner K Ezzedine Umer Nadir Areeba Ahmed Michael D Yi Farhana Ikmal Hisham Loma Dave Brian Cahn Protocol of a scoping review of outcome domains in dermatology BMJ Open |
title | Protocol of a scoping review of outcome domains in dermatology |
title_full | Protocol of a scoping review of outcome domains in dermatology |
title_fullStr | Protocol of a scoping review of outcome domains in dermatology |
title_full_unstemmed | Protocol of a scoping review of outcome domains in dermatology |
title_short | Protocol of a scoping review of outcome domains in dermatology |
title_sort | protocol of a scoping review of outcome domains in dermatology |
url | https://bmjopen.bmj.com/content/14/2/e079632.full |
work_keys_str_mv | AT jamiejkirkham protocolofascopingreviewofoutcomedomainsindermatology AT amitgarg protocolofascopingreviewofoutcomedomainsindermatology AT gregorboruternstjemec protocolofascopingreviewofoutcomedomainsindermatology AT muradalam protocolofascopingreviewofoutcomedomainsindermatology AT phyllisispuls protocolofascopingreviewofoutcomedomainsindermatology AT johnringram protocolofascopingreviewofoutcomedomainsindermatology AT jankottner protocolofascopingreviewofoutcomedomainsindermatology AT kezzedine protocolofascopingreviewofoutcomedomainsindermatology AT umernadir protocolofascopingreviewofoutcomedomainsindermatology AT areebaahmed protocolofascopingreviewofoutcomedomainsindermatology AT michaeldyi protocolofascopingreviewofoutcomedomainsindermatology AT farhanaikmalhisham protocolofascopingreviewofoutcomedomainsindermatology AT lomadave protocolofascopingreviewofoutcomedomainsindermatology AT briancahn protocolofascopingreviewofoutcomedomainsindermatology |